About ELIAS

About ELIAS Animal Health

ELIAS Animal Health is a medical biotechnology company advancing its novel therapies for the treatment of cancer in pets. The company’s lead product candidate, the ELIAS cancer immunotherapy (ECI®), an autologous prescription product, is available to veterinarians under 9 CFR 103.3 as an experimental product. Efficacy and safety have not been established. The company’s novel therapeutic approach offers the promise of improved clinical outcomes and the potential for fundamentally changing the way cancer is treated.

Our mission is to improve cancer treatment outcomes in veterinary patients through the advancement of innovative therapies.

At ELIAS Animal Health:

We are passionate about pets and their healthcare

We are compassionate with pet owners and veterinarians

We make data-driven decisions

We focus on evidence-based scientific claims